| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |